Powered by EMC Captiva InputAccel, Sitrof’s latest solution reduces the time and cost of drug safety intake. By automating the adverse event (AE) intake process regardless of source or medium, the Drug Safety Intake Automation solution empowers Sitrof clients to reduce human error and centralize essential processes while creating a compliant digital archive of critical data. Whether source documentation arrives via paper, digital file transfer, fax, email (with or without an attachment) or as a voice record from a call center, the Drug Safety Intake Automation solution transforms it into an easily searchable digital record and seamlessly integrates with many of the leading pharmacovigilance solutions commercially available today.
"This certification marks a significant milestone for both Sitrof and EMC," said Bryan Reynolds, co-founder and managing partner of Sitrof. "The certification further illustrates Sitrof’s domain expertise delivering meaningful solutions to the life sciences market place. Drug Safety Intake Automation, powered by InputAccel, takes much of the labor and expense out of the intake of unstructured AE source documentation. This enables our clients to meet the rigorous timelines that are defined by the agencies for adverse event reporting.”
Drug Safety Intake Automation, developed by Sitrof Technologies and powered by EMC Captiva InputAccel, is available from both Sitrof (http://www.sitrof.com) and EMC representatives.
About Sitrof Technologies
Sitrof Technologies is a profitable, privately held company with its headquarters in Princeton, N.J. Sitrof provides premier consulting and technology solutions that enable life sciences companies to improve efficiency and mitigate legal and compliance risks. Sitrof’s mission is to provide affordable, state-of-the-